NPPB and COVID-19: We identified that a decreased NT-proCNP level alone or with simultaneously elevated NT-proBNP and inflammatory parameters in COVID-19 patients on admission is significantly associated with a severe disease course (defined as the composite endpoint of need of mechanical ventilatory support/ECMO or death), thus serves as a good marker of poor outcome in COVID-19.